A1 Journal article – refereed

Development of self-assessed work ability among middle-aged asthma patients-a 10 year follow-up study




List of Authors: Eveliina Hirvonen, Antti Karlsson, Maritta Kilpeläinen, Ari Lindqvist, Tarja Laitinen

Publisher: TAYLOR & FRANCIS LTD

Publication year: 2020

Journal: Journal of Asthma

Journal name in source: JOURNAL OF ASTHMA

Journal acronym: J ASTHMA

Number of pages: 9

ISSN: 0277-0903

eISSN: 1532-4303

DOI: http://dx.doi.org/10.1080/02770903.2020.1759089


Abstract
Objective: The prevalence of asthma has been growing among working age people over the last decades. In this study, we examine the development of Work Ability Score (WAS) among middle-aged asthmatics in a longitudinal setting, in order to find risk factors for poor development. Methods: We followed the development of WAS trends during 10 years in a cohort of 529 middle-aged asthmatics, who were active in working life. Follow-up questionnaires were mailed in years 1, 2, 4, 6, 8, and 10. To study the development of WAS over time, we computed the discrete Frechet distance, which describes the similarity between the shapes of WAS curves. Results: Sixty-eight percent of the patients' WAS remained good or excellent throughout the follow-up period, while 24% of the patients WAS trend remained moderate. However, in 8%, the WAS was poor already in baseline and decreased further throughout the study. Using logistic regression, the moderate/poor development was associated significantly with high body mass index (BMI), pack years, adult onset asthma, physically strenuous work, number of co-morbidities, especially in psychiatric conditions, hypertension, and gastroesophageal reflux disease(GERD). When the model was adjusted for age and gender, adulthood onset of asthma and pack years lost their significance. Based on medication (high dose of inhaled corticosteroids (ICS) and second controller in use), 8% of the patients had severe asthma. Conclusion: In the great majority of middle-aged asthma patients WAS remained stable throughout the follow-up period. However, 8% of the patients, who had more severe asthma and multiple co-morbidities, showed significantly poorer outcomes.


Last updated on 2021-24-06 at 11:22